A clinical trial to study the effects of bevacizumab plus capecitabine vs. bevacizumab alone as maintenance therapy in patients with HER2-negative metastatic breast cancer that has not progressed during initial docetaxel plus bevacizumab therapy

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2009
This article has no abstract
Epistemonikos ID: e3da98baf498e94a127aa2db8784790ebbe0e864
First added on: Apr 16, 2025